This site is intended for health professionals only

Health economics of treating multidrug-resistant Gram-positive infections: a qualitative critique

teaser

This review considers analyses undertaken on the economic impact of healthcare-acquired infections and the pharmacoeconomic impact of new drug therapies, including antibiotics such as linezolid

Dilip Nathwani
MB FRCP DTM&H

Article continues below this sponsored advert
Cogora InRead Image
Explore the latest advances in respiratory care at events delivered by renowned experts from CofE
Advertisement

Consultant Physician and Honorary Professor

Infection Unit
Ninewells Hospital and Medical School
Dundee
UK

SENTRY antimicrobial programme data for 1997






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

×